Venezuela's deputy U.N. military attache backs Guaido
WASHINGTON (Reuters) - Venezuela's deputy U.N. military attache, Colonel Pedro Chirinos, said in a video on social media that he has recognised opposition leader Juan Guaido as the country's interim president, increasing pressure on President Nicolas Maduro. U.S.
WASHINGTON (Reuters) - Venezuela's deputy U.N. military attache, Colonel Pedro Chirinos, said in a video on social media that he has recognised opposition leader Juan Guaido as the country's interim president, increasing pressure on President Nicolas Maduro.
U.S. President Donald Trump's national security adviser John Bolton highlighted Chirinos' announcement in a note posted on Twitter on Wednesday but misidentified him as the military attache to the United Nations.
"Venezuela's military attache to the United Nations, Colonel Pedro Chirinos, has announced his official recognition of Juan Guaido as Interim President of Venezuela," Bolton said in his note.
U.N. spokesman Stephane Dujarric said he was not aware of any notifications from the Venezuelan U.N. mission on changes to its delegation.
(Reporting by David Alexander; Editing by James Dalgleish and Sonya Hepinstall)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Rami Amichay HAIFA, Israel (Reuters) - The ship-to-shore crane paused above the cargo ship just arrived from Dubai, then set its load down on the pier in Israel.
By Noor Zainab Hussain, Carolyn Cohn and Ludwig Burger LONDON/FRANKFURT (Reuters) - The world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigour. Yet, while more than 40 experimental COVID-19 vaccines are being tested on humans, the insurance companies with decades of experience in assessing the risks of clinical trials don't see anything to be unduly concerned about.
By Huw Jones LONDON (Reuters) - The European Union's securities watchdog said it expects to make a statement soon on where shares listed in the bloc must be traded after Britain's full departure from the European Union in December.